StonvexLoading…
StonvexStonvexStonvexCore line items from ELAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.37B | $4.71B | $3.57B | $2.43B |
Operating Income | $87.00M | $-224.00M | $35.00M | $85.00M |
Net Income | $57.00M | $-232.00M | $44.00M | $11.00M |
EPS (Diluted) | $0.11 | $-0.47 | $0.09 | $0.16 |
Total Assets | $13.22B | $13.36B | $13.55B | $13.74B |
Total Liabilities | $6.72B | $6.81B | $6.80B | $6.97B |
Cash & Equivalents | $428.00M | $545.00M | $505.00M | $539.00M |
Free Cash Flow OCF − CapEx | $-38.00M | $284.00M | $238.00M | $111.00M |
Shares Outstanding | 499.38M | 496.98M | 496.83M | 496.65M |